Which Pretext Task Transfers? Self-Supervised Pretraining Objectives for Lung Ultrasound
Read the original on arXiv Computer Vision →The Flow has not summarised this story yet — read it at arXiv Computer Vision.
The Flow has not summarised this story yet — read it at arXiv Computer Vision.
Self-supervised learning (SSL) can reduce the need for labelled medical images, but the choice of pretext objective remains unclear for lung ultrasound (LUS). Contrastive learning, masked reconstructi...
arXiv:2610.03290v1 Announce Type: cross Abstract: Lung ultrasound (LUS) is attractive for tuberculosis (TB) screening at primary-care level, but labelled cohorts are small. Echocardiography carries n...
arXiv:2608.30467v1 Announce Type: new Abstract: Deep-learning models can achieve strong chest X-ray (CXR) classification performance without establishing whether their predictions predominantly rely...
arXiv:2607. 20274v1 Announce Type: cross Abstract: Medical image encoders from different groups are increasingly treated as interchangeable, on the assumption that scale and clinical supervision concentrate their representations onto a shared structure.
arXiv:2610.17573v1 Announce Type: cross Abstract: Self-supervised pretraining has expanded the pool of 3D medical foundation models, but published evaluations use different datasets, endpoints and fi...
Med-AR introduces two autoregressive vision‑language models, Med‑AR‑8B and Med‑AR‑2B, pretrained on structured radiology reports, abnormality‑focused text, and region annotations to address long‑tailed chest X‑ray classification. The models outperform existing contrastive, self‑supervised, and supervised encoders—including Med‑CLIP, CheXFound, EVA‑Base, ARK, and BioViL‑T—across PadChest, MIMIC‑CXR, and CheXpert, achieving higher mean AUROC and AUPRC for head, medium, and tail findings and lower excess area under the risk‑coverage curve. Med‑AR also demonstrates improved selective‑prediction performance, with Med‑AR‑8B raising tail‑label mean AUPRC on MIMIC‑CXR from 0.1033 to 0.1441 and Med‑AR‑2B delivering the strongest discrimination on PadChest.